Importantly, the properties mediated and the effects induced by SPARC suggest that the induction of SPARC administration/expression could counteract risk factors for severe forms of COVID-19, limit the impacts of the pandemic measures during the post-COVID-19 era and even form part of the therapies used for hospitalized COVID-19 patients. This evidence concerns the gene SPARC and COVID-19.